Cargando…
Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies. Although CRC treatment has been significantly improved, patient survival remains low because most patients already have advanced disease at diagnosis. Early screening and diagnosis of tumors is critical; however, the current...
Autores principales: | Dai, Weiping, Wang, Zhan, Liang, Xiaoben, Wang, Miaomiao, Ni, Wanliu, Yang, Ye, Zang, Yuan-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660029/ https://www.ncbi.nlm.nih.gov/pubmed/36388668 http://dx.doi.org/10.21037/jgo-22-968 |
Ejemplares similares
-
Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer
por: Wang, Minghui, et al.
Publicado: (2021) -
The Diagnostic and Prognostic Value of Serum lncRNA NEAT1 in Colorectal Cancer
por: Wang, Yong, et al.
Publicado: (2020) -
LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer
por: Dong, Lujia, et al.
Publicado: (2022) -
Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020) -
Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease
por: Zhu, Yanting, et al.
Publicado: (2022)